AGIBOT Profile
As an innovative pioneer in intelligent surgical robotics, AGIBOT focuses on the R&D and industrialization of intelligent surgical products, centered by robotic systems. Guided by clinical needs and a commitment to independent innovation, we realize our vision of "More Intelligent Healthcare for All", strive to develop and commercialize more innovative, practical, and affordable surgical robots.
Founded in September 2020 and headquartered in Suzhou, China, AGIBOT unites a medtech-integrated team of surgical robotics experts and multidisciplinary professionals. Our full-stack development capabilities span from conceptual design to system integration, supported by a technological innovation platform covering mechanical, electrical, optical, computational, software, and medical engineering disciplines.
The AGIBOT Endoscopic Surgical Robot, has obtained NMPA (National Medical Products Administration) clearance. We are now accelerating clinical adoption and scaling production to deliver more AGIBOT solutions that advance global surgical care.
Vision & Mission
Vision
More Intelligent Healthcare for All.
Vision
More Intelligent Healthcare for All.
Mission
To develop and commercialize more innovative,
practical, and affordable surgical robots.
Mission
To develop and commercialize more innovative,
practical, and affordable surgical robots.
Value
Aligning with customer needs
Getting things done
Innovating Infinitely
Believing is seeing
Openness
Team spirit
Milestones
（ 2025 ）
Mar 26: AGIBOT Endoscopic Surgical Robot received NMPA clearanceMar 26: Achieved ISO 13485:2016 Quality Management System Certification from TÜV SÜD
（ 2024 ）
Dec 5: AGIBOT Endoscopic Surgical Robot completed multi-specialty registration trial enrollment (hepatobiliary surgery, gastrointestinal surgery, thoracic surgery, gynecology)Oct 18: Obtained Jiangsu Provincial Medical Products Administration clearance for first product
Sep 9: AGIBOT Endoscopic Surgical Robot reached 100th clinical procedure milestone at Chinese PLA General Hospital's First Medical Center
Aug 23: AGIBOT Endoscopic Surgical Robot simultaneously completed FIH gynecological surgeries at First Affiliated Hospital of Zhengzhou University and Chinese PLA General Hospital
Jul: Closed Series A funding
Jun 19/20/26: AGIBOT Endoscopic Surgical Robot sequentially conducted FIH surgeries across hepatobiliary, gastrointestinal, and thoracic surgeries, entering multi-department clinical application
Mar 30: AGIBOT Endoscopic Surgical Robot concluded urology registration trial enrollment
（ 2023 ）
Dec 20: AGIBOT Endoscopic Surgical Robot achieved clinical application with FIH urological procedure at Nanjing Drum Tower HospitalDec: Awarded as "Gusu Innovation and Entrepreneurship Leading Talent" and "Jiangsu Provincial Double Innovation Talent"
Dec: Closed Pre-A funding
Sep: AGIBOT Endoscopic Surgical Robot passed type testing certification
Apr: Closed Angel funding
（ 2022 ）
Aug: Awarded "Wujiang District Innovation & Entrepreneurship Leading Talent"Jun 19: AGIBOT Endoscopic Surgical Robot completed first animal test
Apr: Recognized as "Technology-based SME"
（ 2020 ）
Sep: AGIBOT founded in Suzhou
Milestones
Mar 26: Achieved ISO 13485:2016 Quality Management System Certification from TÜV SÜD
Oct 18: Obtained Jiangsu Provincial Medical Products Administration clearance for first product
Sep 9: AGIBOT Endoscopic Surgical Robot reached 100th clinical procedure milestone at Chinese PLA General Hospital's First Medical Center
Aug 23: AGIBOT Endoscopic Surgical Robot simultaneously completed FIH gynecological surgeries at First Affiliated Hospital of Zhengzhou University and Chinese PLA General Hospital
Jul: Closed Series A funding
Jun 19/20/26: AGIBOT Endoscopic Surgical Robot sequentially conducted FIH surgeries across hepatobiliary, gastrointestinal, and thoracic surgeries, entering multi-department clinical application
Mar 30: AGIBOT Endoscopic Surgical Robot concluded urology registration trial enrollment
Dec: Awarded as "Gusu Innovation and Entrepreneurship Leading Talent" and "Jiangsu Provincial Double Innovation Talent"
Dec: Closed Pre-A funding
Sep: AGIBOT Endoscopic Surgical Robot passed type testing certification
Apr: Closed Angel funding
Jun 19: AGIBOT Endoscopic Surgical Robot completed first animal test
Apr: Recognized as "Technology-based SME"
